Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,164 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05791786Recruiting
Registry for suspected amniotic fluid embolism patients
This study builds a long-term registry and sample library for people diagnosed with suspected amniotic fluid embolism (AFE), and for certain related hospital deaths. It helps researchers understand what AFE looks like, how it affects health over time, and how to improve future care.
Houston, TexasAges Any age - NCT05749276RecruitingPhase 1
Daratumumab with chemo for older adults with high-risk AML
This Phase 1 study tests whether adding daratumumab to standard intensive chemotherapy (idarubicin and cytarabine) works safely in people age 60 or older with a higher-risk form of acute myeloid leukemia (AML). It may help improve outcomes, but the main goal is to find the best dosing and safety in this age group.
NantesAges 60 years+ - NCT05771675RecruitingEarly Phase 1
Simvastatin trial for symptom relief in pancreatitis
This early-phase study tests whether simvastatin can improve patient-reported symptoms in people with recurrent acute or chronic pancreatitis. It’s meant to see if the medicine is tolerable and helps with how you feel day to day.
Los Angeles, CaliforniaAges 18–75 - NCT05773872Recruiting
Testing social understanding in narcolepsy and hypersomnia
This study compares “social cognition” (how people recognize and understand others’ thoughts and feelings) in adults with narcolepsy or idiopathic hypersomnia. It may help researchers better understand how these conditions can affect everyday social interactions.
AmiensAges 18 years+ - NCT03265379Recruiting
Registry study for breast cancer invading the chest wall
This study follows people with breast cancer that has spread into the chest wall who are planning full-thickness chest wall surgery. It aims to improve quality of life by collecting real-world information during and after treatment.
Toronto, OntarioAges 18 years+ - NCT05742178Recruiting
Cancer screening outreach and help in select NYC neighborhoods
This study tests an outreach program that helps people who may be behind on cancer screenings get connected to the right care. It mainly aims to reduce missed screenings in specific Brooklyn and Bronx communities.
New York, New YorkAges 21–75 - NCT05689463Recruiting
Testing antibodies in itching after immune therapy
This study checks blood antibodies (BP180 and BP230) in people who develop long-lasting itching after starting immune therapy for cancer. It may help doctors understand why the itching happens and how it relates to autoimmune skin conditions.
RouenAges 18 years+ - NCT05694650Recruiting
Share views on cancer care at home
This study asks patients, caregivers, and cancer team members to share their experiences with “care at home” for people receiving or recently finishing cancer treatment. Your feedback will help the hospital understand what’s working and what could be improved.
Houston, TexasAges 18 years+ - NCT05678309Recruiting
Study to create a patient library for itch without a cause
This trial sets up a patient library for people who have itching with no clear underlying skin or medical cause. It aims to collect patient input and experiences to improve understanding and support for this condition.
BrestAges 18–99 - NCT05588856Recruiting
Improving medical advice through better doctor–patient partnerships
This study looks at whether improving communication between doctors and patients leads to better medical advice for people with chronic lung disease. If you have a confirmed diagnosis and can consent, you may be invited to take part.
SingaporeAges 21–99 - NCT05562258Recruiting
Peer coaching for teens with eating disorders
This study tests a “peer-coaching” program where a teen receives support from someone with lived experience, alongside their care. It may help improve how teens manage their eating disorder treatment and feel supported during recovery.
New York, New YorkAges 12–18 - NCT05588245Recruiting
Community support to help pregnant people during prenatal care
This study tests a community-based support program (“patient navigation”) to help pregnant people with unmet social needs get the care they need. It includes support from early pregnancy through 12 months after delivery and may help if social needs are affecting your prenatal care.
Atlanta, GeorgiaAges 18 years+ - NCT05582551Recruiting
Screening test program for childhood cancer survivor senses
This trial helps improve how doctors check senses like hearing and vision after childhood cancer. It may help you (or your child) get better screening and support early for new or lasting side effects.
St Louis, MissouriAges 7–17 - NCT05573893Recruiting
Real-world study of trastuzumab deruxtecan for HER2 breast cancer
This study looks at how people feel (patient-reported outcomes) and their real-world health data while they receive trastuzumab deruxtecan for advanced HER2-positive, HER2-low, or HER2-ultralow breast cancer. It helps researchers understand what outcomes happen outside of tightly controlled clinical trials.
AmbergAges 18–130 - NCT05535361Recruiting
Testing a bowel device for short bowel syndrome patients
This trial studies whether the Eclipse XL1 system is safe and may help people with short bowel syndrome, in both children and adults. It will check how well the approach works and watch for side effects over the study period.
Palo Alto, CaliforniaAges 3 months–65 years - NCT05544084Recruiting
Patient navigation program for cervical screening in Senegal
This study tests a patient “navigator” approach to improve cervical cancer screening and prevention access in Senegal. You may be invited to help through community education, health facility work, or by being part of a screening-support household.
DakarAges 25–69 - NCT05489705Recruiting
Real-world registry for mavacamten and other obstructive HCM treatments
This study collects real-world information about people with obstructive hypertrophic cardiomyopathy (HCM) who are being treated with mavacamten or other standard medicines. It aims to understand patient characteristics, treatment choices over time, and long-term outcomes.
Anchorage, AlaskaAges 18 years+ - NCT05487846Recruiting
Peer support during genetic testing for metastatic prostate cancer
This trial offers support from a trained peer to help African American men understand and go through genetic testing for prostate cancer. It may help you feel less overwhelmed and better prepared during the testing and decision-making process.
Philadelphia, PennsylvaniaAges 18 years+ - NCT05431946Enrolling by invitation
Palliative care support for people with liver cirrhosis
This trial studies a palliative care approach—comfort-focused support aimed at improving quality of life—for people with liver cirrhosis. It may help by addressing symptoms and planning care together with you and your family.
EsbjergAges 18 years+ - NCT05452356Recruiting
Testing a phone-based care plan for people with heart conditions
This trial tests a phone app that helps deliver organized “care plans” for people with cardiovascular (heart/vessel) conditions. You might join to see if this phone-based support improves how care is delivered and helps you manage your condition.
London, OntarioAges 18 years+ - NCT05364606Recruiting
Patient-specific ankle spacer for avascular necrosis after surgery
This study follows people who are getting a custom-made spacer implanted in the ankle for avascular necrosis. It’s mainly checking what happens after the surgery in real-world care, and it may help improve how these implants are used and tracked over time.
Santa Rosa, CaliforniaAges 21 years+ - NCT05407129Recruiting
Improve hospital safety by sharing your recent experience
This trial asks patients, families, caregivers, and hospital staff to report what happened during a recent hospital stay to help improve safety. Your feedback may help the hospital change processes that prevent problems for others.
Boston, MassachusettsAges Any age - NCT05410275RecruitingPhase 3
Low-dose rivaroxaban for dialysis patients without blood thinners
This study tests whether a lower dose of the blood thinner rivaroxaban is safe for people with kidney failure on dialysis who do not already need blood thinners. The goal is to find a way to prevent blood clots and strokes with less risk of bleeding.
ToursAges 18 years+ - NCT05349513Recruiting
Testing a home-care program for schizophrenia-like disorders
This study tests a specific kind of care delivered in a home-like setting for people with schizophrenia or schizoaffective disorder. It may help the care team understand what kinds of supports work best and improve day-to-day treatment.
PoitiersAges 18–65
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,164 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.